Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral blood biomarkers RCAN1, Clusterin, RAGE, and malondialdehyde for early diagnosis and progression of Alzheimer's disease.

BMC medicine·2026
Same author

MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders.

Cancer research·2026
Same author

Sensory deficiencies correlate with tau protein and dementia.

Frontiers in neuroscience·2026
Same author

Structure and function of Full-length Tau.

PloS one·2025
Same author

Amyloid and tau pathologies cross-talk to promote Alzheimeŕs disease: novel mechanistic insights.

Neuroscience·2025
Same author

Tau aggregation.

Histology and histopathology·2025

Related Experiment Video

Updated: Jun 10, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Intracellular and extracellular tau.

Jesús Avila1

  • 1Centro de Biología Molecular "Severo Ochoa", Campus Cantoblanco, Universidad Autónoma de Madrid Madrid, Spain.

Frontiers in Neuroscience
|July 28, 2010
PubMed
Summary

This review covers the toxicity of modified intracellular tau protein and extracellular tau released after neuron death. Understanding tau toxicity is crucial for neurodegenerative disease research.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Toxicology

Background:

  • Tau protein plays a critical role in neuronal function.
  • Aberrant tau pathology is a hallmark of several neurodegenerative diseases.
  • Both intracellular and extracellular tau species can exert toxic effects.

Purpose of the Study:

  • To review the toxicity associated with modified intracellular tau.
  • To discuss the toxicity of extracellular tau released post-neuron death.
  • To consolidate understanding of tau's dual localization toxicity.

Main Methods:

  • Literature review of existing studies on tau protein.
  • Analysis of research on intracellular tau modifications.
  • Examination of studies investigating extracellular tau release and toxicity.
Keywords:
Alzheimer diseasetautauopathiestoxicity

More Related Videos

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
09:12

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes

Published on: December 20, 2019

Related Experiment Videos

Last Updated: Jun 10, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
09:12

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes

Published on: December 20, 2019

Main Results:

  • Modified intracellular tau exhibits significant toxicity.
  • Extracellular tau, released from dying neurons, also contributes to neurotoxicity.
  • Tau's toxicity is dependent on its localization and modification state.

Conclusions:

  • Both intracellular and extracellular tau species are toxic.
  • Tau pathology contributes to neurodegeneration through multiple mechanisms.
  • Further research into tau toxicity is warranted for therapeutic development.